• 3902 Citations
  • 33 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Platinum Medicine & Life Sciences
Growth Medicine & Life Sciences
Aurora Kinases Medicine & Life Sciences
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

ADH1B promotes mesothelial clearance and ovarian cancer infiltration

Gharpure, K. M., Lara, O. D., Wen, Y., Pradeep, S., LaFargue, C., Ivan, C., Rupaimoole, R., Hu, W., Mangala, L. S., Wu, S., Nagaraja, A. S., Baggerly, K. A. & Sood, A. K., May 18 2018, In : Oncotarget. 9, 38, p. 25115-25126 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Adjuvant Chemotherapy
Cell Adhesion
Extracellular Matrix
Aurora Kinases
Valproic Acid

Inhibiting nuclear phospho-progesterone receptor enhances antitumor activity of onapristone in uterine cancer

Huang, Y., Hu, W., Huang, J., Shen, F., Sun, Y., Ivan, C., Pradeep, S., Dood, R., Haemmerle, M., Jiang, D., Mangala, L. S., Noh, K., Hansen, J. M., Dalton, H. J., Previs, R. A., Nagaraja, A. S., McGuire, M., Jennings, N. B., Broaddus, R., Coleman, R. & 1 othersSood, A. K., Feb 1 2018, In : Molecular Cancer Therapeutics. 17, 2, p. 464-473 10 p.

Research output: Contribution to journalArticle

Uterine Neoplasms
Progesterone Receptors
Epidermal Growth Factor
4 Citations

Paclitaxel with and without pazopanib for persistent or recurrent ovarian cancer: A randomized clinical trial

Richardson, D. L., Sill, M. W., Coleman, R., Sood, A. K., Pearl, M. L., Kehoe, S. M., Carney, M. E., Hanjani, P., Van Le, L., Zhou, X. C., Secord, A. A., Gray, H. J., Landrum, L. M., Lankes, H. A., Hu, W. & Aghajanian, C., Feb 1 2018, In : JAMA Oncology. 4, 2, p. 196-202 7 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Randomized Controlled Trials
Disease-Free Survival
1 Citations

The role of tumor microenvironment in resistance to anti-angiogenic therapy

Sood, A. K., Ma, S., Pradeep, S., Hu, W., Zhang, D. & Coleman, R., Jan 1 2018, In : F1000Research. 7, 326.

Research output: Contribution to journalReview article

Tumor Microenvironment
Stromal Cells
Drug Resistance